How to Access Screening Libraries and HTS Outside the Pharma World
Conference Recording Dec 18, 2013
About the Speaker
Carsten Claussen is the founding CEO of the European ScreeningPort GmbH, a public private partnership for drug discovery services. He has wide executive management experience, including as CEO of Evotec Technologies, now part of PerkinElmer, Inc., and as Member of Evotec AG’s Executive Management Committee. Carsten is Guest Professor for Entrepreneurship and sits on the boards of several start-up companies.
What are the right strategies to build up compound collections outside the safe-guarded pharma collections to generate 'starting points' and 'tool compounds'. Besides the scale, design, quality of the collection the uniqueness, the operation, the follow up, IP and the budgets have to be addressed.
Comments | 0 ADD COMMENT
Orphan Drugs and Rare Diseases Global Congress 2017 USA
Sep 12 - Sep 14, 2017